• SENSEX 76,261.25
    -1,153.67 (--1.49%)
  • BANKNIFTY 51,564.85
    -11.00 (--0.02%)
  • Vodafone Idea
    8.03 19.15(%)
  • Hind.Aeronautics
    4,492.80 5,675.00(%)
  • HBL Engineering
    530.75 738.65(%)
  • Reliance Industr
    1,256.70 1,156.00(%)
  • HDFC Bank
    1,772.35 1,430.15(%)
  • Larsen & Toubro
    3,440.50 3,141.30(%)
  • Adani Green
    927.05 758.00(%)
  • ITC
    414.30 500.01(%)
  • IndusInd Bank
    689.85 1,576.00(%)
  • ICICI Bank
    1,324.00 1,048.35(%)
  • Trent
    5,619.85 8,345.85(%)
  • Zomato Ltd
    205.00 304.50(%)
  • A B B
    5,415.75 4,893.10(%)
  • St Bk of India
    763.05 679.65(%)
  • Infosys
    1,518.00 1,359.10(%)
  • M & M
    2,634.50 1,872.45(%)
  • Nip. India Gold
    76.38 74.79(%)
  • Mazagon Dock
    2,591.35 920.48(%)
  • Bajaj Finance
    8,702.90 6,376.55(%)
  • Tata Motors
    666.00 606.20(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Fermenta Biotech Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 146.0
  • ISIN : INE225B01021
273.55 4 (1.31%)
  • As on 01 Apr 2025 (EOD)

  • Today’s Low

    270.50

  • Today’s High

    283.45

  • Open

    270.55

  • Perv Close

    270.00

  • 52W Low

    145.00

  • 52W High

    449.00

Key Indicators

  • P/E(TTM)

    25.93

  • Mar.Cap (₹Cr.)

    805.08

  • Div & Yield %

    0.45

  • Book Value(₹)

    107.10

  • Debt-Equity Ratio

    1.31

  • AGM Date

    28-Mar-2025

  • EPS

    10.55

  • P/E Ratio

    25.93

Financials Ratios

  • Debt-Equity Ratio

    0.59

  • Mar.Cap (₹Cr.)

    805.08

  • RONW (%)

    -5.82

  • ROCE (%)

    2.96

Score Board

  • Equity (₹ in Cr.)

    14.72

  • BV (₹)

    107.10

  • Sales( ₹ in Cr.)

    307.09

  • NP (in Cr.)

    -7.74

  • NP Var(%)

    -351.0

  • Div%

    25.0

  • CPS (₹)

    5.40

  • EPS (₹)

    -2.60

  • Traded Value (₹ in Lakhs)

    805.08

  • 52 Week High

    449.00

  • 52 Week Low

    145.00

  • Price BSE

    274.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    805.08

  • P/C Ratio

    50.50

  • P/E Ratio

    -104.20

  • Price Vs.BV

    -2.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 307.09 328.91 387.96 372.82 300.51 404.67
Excise Duty 229.44 262.74 370.49 349.01 275.43 376.64
Net Sales 307.09 328.91 387.96 372.82 300.51 404.67
Other Income 8.15 8.46 7.53 6.62 12.31 12.34
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 315.24 337.38 395.49 379.44 311.58 415.80
EXPENDITURE :
Raw Materials 229.44 262.74 370.49 349.01 275.43 376.64
Power & Fuel Cost 229.44 262.74 370.49 349.01 275.43 376.64
Employee Cost 53.93 53.81 59.36 57.50 50.03 53.18
Other Manufacturing Expenses 6.22 9.09 6.30 10.43 9.20 18.66
Selling & Administrative Expenses 34.46 38.73 38.16 44.39 54.98 57.88
Miscellaneous Expenses 6.22 9.09 6.30 10.43 9.20 18.66
Less : Pre-operative Expenses Capitalised :
Total Expenditure 310.85 335.76 352.92 316.21 264.04 294.68
Operating Profit 70.07 62.36 64.00 43.14 32.89 40.20
Interest 17.05 20.80 17.23 18.07 19.32 20.65
Gross Profit -4.61 -57.98 42.56 63.23 47.55 121.12
Depreciation 23.70 24.49 23.67 19.03 14.94 11.85
Profit Before Tax -4.61 -57.98 42.56 63.23 47.55 121.12
Tax 1.68 0.18 7.41 11.26 3.37 31.92
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 4.92 0.00 -19.49 -21.15
Reported Net Profit -18.74 -57.00 30.24 51.97 63.67 110.35
Extraordinary Items -4.61 -57.98 42.56 63.23 47.55 121.12
Adjusted Net Profit -18.74 -57.00 30.24 51.97 63.67 110.35
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 3.68 3.68 3.68 7.21 4.81 1.15
P & L Balance carried down -18.74 -57.00 30.24 51.97 63.67 110.35
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 25.00 25.00 25.00 50.00 100.00 25.00
Dividend Per Share(Rs) 1.25 1.25 1.25 2.50 5.00 1.25
Earnings Per Share-Unit Curr -6.49 -19.75 10.48 18.02 22.07 38.25
Book Value 3.68 3.68 3.68 7.21 4.81 1.15
Book Value(Adj)-Unit Curr 3.68 3.68 3.68 7.21 4.81 1.15

Shareholding Pattern

  • Promoter Group

    62.06%

  • Public Share Holding

    37.00%

  • Custodian

    0.94%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 2,240,376 2,240,376.00 2,240,376 2,240,376
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 2,240,376 7.61 2,240,376 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 16,024,815 54.45 16,024,815 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 16,024,815 54.45 16,024,815 3
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 120 0.00 120 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 7,298 0.02 7,298 2
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 7,418 0.03 7,418 3
2] Non Institution
Bodies Corporate 608,224 2.07 607,624 107
Clearing Members 1,250 0.00 1,250 2
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 241,312 0.82 241,312 280
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 270,986 0.92 270,986 395
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 4,106,933 13.95 4,106,933 26
Individuals holding nominal share capital up to Rs. 1 lakh 5,402,500 18.36 5,157,449 12,089
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 46,800 0.16 46,800 1
Others 172,926 0.59 172,926 1
Sub Total 10,882,020 36.97 10,636,369 12,914
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 276,358 0.94 276,358 1
Total Shares held by Custodians and against which Depository Receipts have been issued 276,358 0.94 276,358 1
Grand Total ( A + B + C ) 29,430,987 100.00 29,185,336 12,922

Company Background

Fermenta Biotech LtdPharmaceuticals - Indian - Bulk Drugs

  • Fermenta Biotech Ltd
  • BSE Code : 146.0
  • ISIN : INE225B01021

  • Incorporation Year

    1951

  • Registered Office

    A-1501 DIL Complex Majiwada
    Ghodbunder Road Thane One, Thane (West),
    Maharashtra-400610

  • Telephone

    91-22-66230800/888

  • FAX

    91-22-67980899

  • Chairman

    Pradeep Manjunath Chandan

  • Managing Director

    Prashant Nagre

  • Company Secretary

    Srikant N Sharma

  • Auditor

    S R B C & Co LLP

  • Face Value

    5

  • Listing

    BSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Fermenta Biotech Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Fermenta Biotec. 273.55 315.24 307.09 25.93 4.10
Abbott India 30,730.65 6,097.18 5,848.91 48.94 44.71
Astrazeneca Phar 8,606.35 1,330.33 1,295.53 221.87 33.26
P & G Health Ltd 5,142.30 1,166.89 1,151.26 36.08 39.76
Glaxosmi. Pharma 2,877.30 3,530.73 3,407.25 57.21 44.44
Cipla 1,441.70 17,645.00 16,574.34 24.72 20.10
Novartis India 785.05 396.75 335.07 22.47 15.57
Amrutanjan Healt 644.85 437.58 421.23 37.80 20.84
Guj. Themis Bio. 281.50 174.19 169.82 58.28 44.82
Bliss GVS Pharma 117.55 638.96 605.46 26.90 11.19
Ambalal Sarabhai 35.05 11.70 3.81 14.98 1.92